5-150004857-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014983.3(HMGXB3):c.5A>G(p.Asp2Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 152,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014983.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGXB3 | NM_014983.3 | c.5A>G | p.Asp2Gly | missense_variant | Exon 2 of 20 | ENST00000502717.6 | NP_055798.3 | |
HMGXB3 | NM_001366501.2 | c.5A>G | p.Asp2Gly | missense_variant | Exon 2 of 19 | NP_001353430.1 | ||
HMGXB3 | XM_047416963.1 | c.5A>G | p.Asp2Gly | missense_variant | Exon 2 of 12 | XP_047272919.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGXB3 | ENST00000502717.6 | c.5A>G | p.Asp2Gly | missense_variant | Exon 2 of 20 | 1 | NM_014983.3 | ENSP00000421917.1 | ||
HMGXB3 | ENST00000613459.4 | c.743A>G | p.Asp248Gly | missense_variant | Exon 3 of 21 | 5 | ENSP00000479027.1 | |||
HMGXB3 | ENST00000503427.5 | c.5A>G | p.Asp2Gly | missense_variant | Exon 2 of 21 | 5 | ENSP00000422231.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5A>G (p.D2G) alteration is located in exon 2 (coding exon 1) of the HMGXB3 gene. This alteration results from a A to G substitution at nucleotide position 5, causing the aspartic acid (D) at amino acid position 2 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at